en
Feedback
Chennai Trading Academy

Chennai Trading Academy

Open in Telegram

Not SEBI registered Trades given in this group are for educational purposes only. Consult your financial advisor before taking any trade and trade at your own risk.

Show more

📈 Analytical overview of Telegram channel Chennai Trading Academy

Channel Chennai Trading Academy (@ctanarayanan) in the English language segment is an active participant. Currently, the community unites 20 820 subscribers, ranking 5 983 in the Economy & Finance category and 20 241 in the India region.

📊 Audience metrics and dynamics

Since its creation on невідомо, the project has demonstrated rapid growth, gathering an audience of 20 820 subscribers.

According to the latest data from 21 July, 2026, the channel demonstrates stable activity. Although there has been a change in the number of participants by 58 over the last 30 days and by 36 over the last 24 hours, overall reach remains high.

  • Verification status: Not verified
  • Engagement rate (ER): The average audience engagement rate is 11.38%. Within the first 24 hours after publication, content typically collects 10.23% reactions from the total number of subscribers.
  • Post reach: On average, each post receives 2 369 views. Within the first day, a publication typically gains 2 130 views.
  • Reactions and interaction: The audience actively supports content: the average number of reactions per post is 3.
  • Thematic interests: Content is focused on key topics such as hdfc, yoy, crore, insurance, ipo.

📝 Description and content policy

The author describes the resource as a platform for expressing subjective opinions:
Not SEBI registered Trades given in this group are for educational purposes only. Consult your financial advisor before taking any trade and trade at your own risk.

Thanks to the high frequency of updates (latest data received on 22 July, 2026), the channel maintains relevance and a high level of publication reach. Analytics show that the audience actively interacts with content, making it an important point of influence in the Economy & Finance category.

20 820
Subscribers
+3624 hours
+1087 days
+5830 days
Attracting Subscribers
July '26
July '26
+250
in 0 channels
June '26
+324
in 0 channels
Get PRO
May '26
+186
in 0 channels
Get PRO
April '26
+120
in 0 channels
Get PRO
March '26
+358
in 0 channels
Get PRO
February '26
+775
in 1 channels
Get PRO
January '26
+455
in 0 channels
Get PRO
December '25
+193
in 1 channels
Get PRO
November '25
+250
in 0 channels
Get PRO
October '25
+287
in 0 channels
Get PRO
September '25
+189
in 0 channels
Get PRO
August '25
+173
in 0 channels
Get PRO
July '25
+139
in 0 channels
Get PRO
June '25
+287
in 1 channels
Get PRO
May '25
+491
in 1 channels
Get PRO
April '25
+377
in 0 channels
Get PRO
March '25
+313
in 1 channels
Get PRO
February '25
+489
in 1 channels
Get PRO
January '25
+711
in 0 channels
Get PRO
December '24
+184
in 0 channels
Get PRO
November '24
+296
in 0 channels
Get PRO
October '24
+139
in 1 channels
Get PRO
September '24
+388
in 0 channels
Get PRO
August '24
+184
in 2 channels
Get PRO
July '24
+269
in 1 channels
Get PRO
June '24
+137
in 1 channels
Get PRO
May '24
+40
in 1 channels
Get PRO
April '24
+37
in 0 channels
Get PRO
March '24
+47
in 0 channels
Get PRO
February '24
+342
in 0 channels
Get PRO
January '24
+281
in 1 channels
Get PRO
December '23
+288
in 0 channels
Get PRO
November '23
+166
in 0 channels
Get PRO
October '23
+120
in 2 channels
Get PRO
September '23
+198
in 0 channels
Get PRO
August '23
+302
in 0 channels
Get PRO
July '23
+391
in 0 channels
Get PRO
June '23
+196
in 0 channels
Get PRO
May '23
+170
in 0 channels
Get PRO
April '23
+111
in 0 channels
Get PRO
March '23
+282
in 0 channels
Get PRO
February '23
+159
in 0 channels
Get PRO
January '23
+191
in 0 channels
Get PRO
December '22
+111
in 0 channels
Get PRO
November '22
+93
in 0 channels
Get PRO
October '22
+95
in 0 channels
Get PRO
September '22
+314
in 0 channels
Get PRO
August '22
+190
in 0 channels
Get PRO
July '22
+86
in 0 channels
Get PRO
June '22
+90
in 0 channels
Get PRO
May '22
+176
in 0 channels
Get PRO
April '22
+229
in 0 channels
Get PRO
March '22
+100
in 0 channels
Get PRO
February '22
+91
in 0 channels
Get PRO
January '22
+3 310
in 0 channels
Get PRO
December '21
+133
in 0 channels
Get PRO
November '21
+126
in 0 channels
Get PRO
October '21
+542
in 0 channels
Get PRO
September '21
+565
in 0 channels
Get PRO
August '21
+5 191
in 0 channels
Get PRO
July '21
+443
in 0 channels
Get PRO
June '21
+1 295
in 0 channels
Get PRO
May '21
+571
in 0 channels
Get PRO
April '21
+207
in 0 channels
Get PRO
March '21
+359
in 0 channels
Get PRO
February '21
+467
in 0 channels
Get PRO
January '21
+17 283
in 0 channels
Date
Subscriber Growth
Mentions
Channels
22 July+9
21 July+42
20 July0
19 July0
18 July+19
17 July+18
16 July+29
15 July+28
14 July0
13 July+1
12 July0
11 July0
10 July0
09 July+5
08 July+40
07 July+23
06 July0
05 July+2
04 July0
03 July+9
02 July0
01 July+25
Channel Posts
Intraday levels in NIFTY AND BANKNIFTY , please msg to WhatsApp number by clicking the below Link 》》 https://wa.me/919003091909?text=I%20Want%20To%20Open%20an%20Account Intraday levels in CRUDEOIL AND NATURAL GAS, please msg to WhatsApp number by clicking the below Link 》》 https://wa.me/919003091909?text=I%20Want%20To%20Open%20an%20Accout

2
https://youtu.be/gKWbn1zDnAg
1 271
3
*𝗥𝗘𝗦𝗨𝗟𝗧𝗦 𝗧𝗼𝗺𝗼𝗿𝗿𝗼𝘄 𝗧𝗵𝘂𝗿𝘀𝗱𝗮𝘆 𝗡𝗶𝗳𝘁𝘆 Stocks 𝗜𝗡𝗙𝗢𝗦𝗬𝗦 𝗜𝗡𝗧𝗘𝗥𝗚𝗟𝗢𝗕𝗘 𝗖𝗜𝗣𝗟𝗔 F&O Stocks 𝗠𝗢𝗙𝗦𝗟 𝗩𝗜𝗦𝗛𝗔𝗟 𝗠𝗘𝗚𝗔 𝗠𝗔𝗥𝗧 𝗦𝗢𝗡𝗔 𝗕𝗟𝗪 𝗠𝗣𝗛𝗔𝗦𝗜𝗦 𝗜𝗘𝗫 𝗖𝗮𝘀𝗵 Stocks 𝗠𝗘𝗘𝗦𝗛𝗢 𝗖𝗢𝗥𝗢𝗠𝗔𝗡𝗗𝗘𝗟 𝗜𝗡𝗧𝗘𝗥𝗡𝗔𝗧𝗜𝗢𝗡𝗔𝗟 𝗚𝗢 𝗗𝗜𝗚𝗜𝗧 𝗖𝗛𝗘𝗡𝗡𝗔𝗜 𝗣𝗘𝗧𝗥𝗢 𝗔𝗟𝗟𝗜𝗘𝗗 𝗕𝗟𝗘𝗡𝗗𝗘𝗥𝗦 𝗨𝗝𝗝𝗜𝗩𝗔𝗡 𝗦𝗙𝗕 𝗣𝗩𝗥𝗜𝗡𝗢𝗫 𝗖𝗬𝗜𝗘𝗡𝗧 𝗧𝗛𝗬𝗥𝗢𝗖𝗔𝗥𝗘 𝗧𝗘𝗖𝗛𝗡𝗢𝗟𝗢𝗚𝗜𝗘𝗦 𝗠𝗔𝗛𝗜𝗡𝗗𝗥𝗔 𝗟𝗜𝗙𝗘𝗦𝗣𝗔𝗖𝗘 𝗥𝗢𝗨𝗧𝗘 𝗠𝗢𝗕𝗜𝗟𝗘 𝗦𝗣𝗔𝗡𝗗𝗔𝗡𝗔 𝗦𝗣𝗛𝗢𝗢𝗥𝗧𝗬 𝗦𝗨𝗥𝗬𝗢𝗗𝗔𝗬 𝗦𝗙𝗕 𝗖𝗔𝗣𝗜𝗧𝗔𝗟 𝗦𝗙𝗕*
1 548
4
NESTLE Stellar Set! Massive Beat on Revenue, EBITDA & PAT - Revenue at 6378 Cr vs Poll at 6065 Cr - EBITDA at 1538 Cr vs Poll at 1375 Cr - Margins at 24% vs Poll at 22.7% - PAT at 975 Cr vs Poll at 857 Cr YoY Growth - Revenue +25% - EBITDA +40% - PAT +48% Key Internals - Strong quarter led by volume growth - Domestic Sales +25%, Exports +36% - Accelerated operational cost savings, yet grew ad spends by >40% - All product groups delivered strong double-digit growth
1 982
5
No text...
1 916
6
No text...
1 857
7
BSE In Focus – Set To Be Part Of Nifty 50? NSE circular on NIFTY 50 came yesterday NSE uploaded the methodology for index rej+1
BSE In Focus – Set To Be Part Of Nifty 50? NSE circular on NIFTY 50 came yesterday NSE uploaded the methodology for index rejig No change in methodology As per this, BSE is set to be part of the Nifty 50 index, replacing Wipro As per an earlier Axis Cap note, BSE inclusion will lead to passive inflow of $657 million (around Rs 6300 cr)
1 718
8
10 Years no return Symphony -5% SPARC: -5% Emami: -5% Network18: -3% Huhtakami: -2% ACC: -2% Blue Dart: -2% PNB: -2% Castrol: -1% Whirlpool: 0% PVR Inox: -0.5% Amara Raja 0% LIC Housing: 1% Shopperstop 1% Indus Tower 1% Kiri Ind: 1.5% Nilkamal: 1.50% ITC: +2% IDBI: +2% Bata: +2% VST Ind: 2% JK Lakshmi Cem: 3% Just Dial: 3% Jyoti Lab: 3% Dabur: 3% Hero Moto: 4%
1 407
9
https://youtube.com/shorts/SfUDk08aF3U?si=NuCrEiwx1q2tc1Rm
1 329
10
Trump’s Generic Pharma Tariff Plan: Winners & Losers? 🇺🇸 Proposed policy: ✅0% tariff on imported generic drugs for the next 2 years (from Aug 1). 🙁100% tariff in Year 3. 🙁200% tariff thereafter. Likely impact (if implemented): 🟢 Potential Beneficiaries 🔥Aurobindo Pharma – Strong US manufacturing footprint. 🔥Senores Pharma – Local US manufacturing could be an advantage. ☠️Sentimentally Negative 🙁Dr. Reddy’s 🙁Lupin 🙁Cipla 🙁Zydus (US manufacturing exists but may not be sufficient if tariffs become steep.) ⚪ Largely Neutral 😄Alkem 😄Torrent (Lower dependence on US generics profits.) If this policy becomes reality, manufacturing location could become as important as product quality.
1 332
11
Strong growth by NESTLE in Q1 Double Digit volume growth delivered in the quarter Stock up 3% post results
Strong growth by NESTLE in Q1 Double Digit volume growth delivered in the quarter Stock up 3% post results
1 406
12
SOLID + BUMPER Results from TVS Motors EBITDA growth is more than 40%
SOLID + BUMPER Results from TVS Motors EBITDA growth is more than 40%
1 472
13
NEGATIVE FOR INDIAN PHARMA STOCKS This is an unexpected development given the past news flow on this account Expect knee jerk negative reaction across the board for Indian generic cos with large US exposure - Auro, Zydus, Lupin, DRL most exposed in large caps; Strides, Rubicon etc in smaller names; cos like sun with limited generic exposure, Cipla with a relatively stronger US mfg base are relatively better placed at the margin Beyond the headlines, too many unanswered questions - does it apply only to formulations or also on APIs, are countries with trade deal exempted as is with branded drugs: clarity will emerge only when the formal regulations are issued The tariff threat for branded drugs was managed by agreements between big pharma and Trump admin, country level trade deals and a flurry of capex announcements BROKER NOTE
1 672
14
ADANIENT hit day high...Watch Adani stocks
1 757
15
WIPRO hit day high….Watch IT stocks
1 812
16
DATAPATTNS Up 4% Today….Good Volume
1 814
17
NIFTY SPOT NEAR 24000 NOW THIS IS LAST 8 SESSION LOW THIS WILL KEEP CRUCIAL SUPPORT TODAY
1 912
18
MotilalOswalLtd note: Paytm - Revenue growth steady; EBITDA margin improves | Neutral | TP INR1,475
1 973
19
ALL SECTORAL INDICES except Auto down Today Nifty Auto Up +0.6% Today PSU Bank & Pharma Leads the Fall
2 021
20
KALYANKJIL Trading Near 52 Week High....Good Volume Stock Up 2% Today
2 021